January 17, 2019

Article: Process optimisation in development of biosimilars

Process optimisation for biologics is obligatory for efficient processing and reduction of Cost of Goods (COGs). Especially in the development of biosimilars. In the current issue of European Biotechnology, Louis Boon (Chief Scientific Officer at Bioceros) describes advantages of using Bioceros’ CHO-BC® platform, easy to transfer to the development laboratories of Polpharma Biologics, in process […]

Read More

October 30, 2018

Join us at BIO-Europe Conference

Polpharma Biologics participates in 24th BIO-Europe conference in Copenhagen (Denmark) where we present our fully integrated one-stop-shop CDMO offer. This year Europe’s largest life science partnering event takes place from 5th to 7th November. Industry representatives from more than 2100 companies and over 60 countries will be pleased to meet and talk to potential customers and […]

Read More

September 28, 2018

Polpharma Biologics Launches New Website

Polpharma Biologics, the biopharmaceutical division of Polpharma Group, is pleased to introduce a new website highlighting our end-to-end capabilities in the development and manufacture of biologics and biosimilars. In addition to providing in-depth information on our world-class expertise and facilities, the new website serves to further define our position as both a one-stop-shop CDMO and […]

Read More


For media inquiries, please contact:

Kamila Oliwa-Stasiak,

Senior Communication Specialist.